Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, non-blinded, multi-center, non-inferiority trial designed
to compare effectiveness and side-effects of methotrexate versus prednisolone as first-line
therapy for pulmonary sarcoidosis..